聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 15 分钟 47 秒 前

Sorrento Therapeutics Appoints Amar Singh as Executive Vice President and Chief Business Officer

周三, 01/08/2014 - 13:36
SAN DIEGO, Jan. 8, 2014 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento; www.sorrentotherapeutics.com), a late-stage clinical oncology company developing new treatments for cancer and associated pain, today...
Biopharmaceuticals, Oncology, Personnel
Sorrento Therapeutics, Cynviloq, paclitaxel

Targacept Appoints John P. Richard as Chairman of the Board of Directors

周三, 01/08/2014 - 13:31
WINSTON-SALEM, N.C.--(Healthcare Sales & Marketing Network)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that John P. Richard, a Targacept non-executive director since Novem...
Biopharmaceuticals, Personnel
Targacept, NNR Therapeutics

Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension

周三, 01/08/2014 - 13:25
WHITEHOUSE STATION, N.J.--(Healthcare Sales & Marketing Network)--Merck (MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) recently approved ISENTRESS® for oral suspension, a new p...
Biopharmaceuticals, HIV/AIDS, FDA
Merck, ISENTRESS, raltegravir, antiretroviral

Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash

周三, 01/08/2014 - 13:17
Acquisition is Immediately Accretive Adds Nearly $700 million to FY2015 Revenues Company Expects to Achieve $125 Million in Synergies by FY2016 Accretive to FY2015 Non-GAAP EPS by Approximately $0.78 Diversifies Forest Offerings in Key Therapeu...
Biopharmaceuticals, Mergers & Acquisitions
Forest Laboratories, Aptalis, ZENPEP, CANASA, CARAFATE

Encision Files 510(k) with FDA for AEM(R) Simplification Product

周三, 01/08/2014 - 13:11
BOULDER, Colo., Jan. 8, 2014 -- (Healthcare Sales & Marketing Network) -- Encision Inc. (ECIA:PK), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, announced today that i...
Devices, Surgery, FDA
Encision, EndoShield, Burn Protection System, energy burns, AEM monitoring

Genetic Technologies Announces New Record Growth in Number of BREVAGen(TM) Tests Received for December Quarter

周三, 01/08/2014 - 13:06
MELBOURNE, AUSTRALIA--(Healthcare Sales & Marketing Network) - Genetic Technologies Limited (NASDAQ: GENE) (ASX: GTG) today announced that a new record number of BREVAGen™ test samples were received during the quarter ended December 31, 2013. Total patient...
Diagnostics, Oncology
Genetic Technologies Limited, BREVAGen, breast cancer, breast cancer risk

BIND Therapeutics Announces Departure of Chief Medical Officer

周二, 01/07/2014 - 22:27
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--BIND Therapeutics, Inc. (BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced that Greg Berk, M.D., Chief Medica...
Biopharmaceuticals, Oncology, Personnel
BIND Therapeutics, Accurins

Lipocine Announces New Appointments to Its Board of Directors

周二, 01/07/2014 - 22:25
SALT LAKE CITY, Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Lipocine Inc. (LPCN) (LPCN), a specialty pharmaceutical company, today announced changes to the Company's Board of Directors, including the appointments of Dr. Stephen Hill, Mr. Jeff...
Biopharmaceuticals, Drug Delivery, Personnel
Lipocine

Mylan Launches Generic Detrol(R) LA Capsules

周二, 01/07/2014 - 22:22
PITTSBURGH, Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Mylan Inc. (MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release (ER) Capsules, 2 mg and 4 mg. Tolterodine T...
Biopharmaceuticals, Generics, Urology, Product Launch
Mylan Pharmaceuticals, Tolterodine, Pfizer, Detrol LA

Beth Israel Deaconess Medical Center Uses Carestream’s DRX Systems to Enhance Diagnosis, Treatment of Critical Care Patients

周二, 01/07/2014 - 19:12
Rapid Capture and Delivery of X-ray Images Helped Save Lives for Patients Injured During Boston Marathon Bombings, Says Radiology Department Manager ROCHESTER, N.Y.--(Healthcare Sales & Marketing Network)--Beth Israel Deaconess Medical Center (Boston, M...
Devices, Radiology
Carestream Health, DRX-Revolution, Mobile X-Ray, imaging

Oculus Innovative Sciences Introduces Two New Microcyn(R) Advanced Wound Care Products for U.S. Prescription Wound Care Market

周二, 01/07/2014 - 18:45
New three-ounce Microcyn(R) Skin & Wound Spray HydroGel delivers wound hydrogel to entire wound site via innovative spray application Microcyn Skin & Wound Care now available in convenient two-ounce bottle for both clinical and economical in-home patien...
Biopharmaceuticals, Wound Care
Oculus Innovative Sciences, Microcyn, hydrogel

FDA Clears IsoRay's Liquid Cesium (Cesitrex)(TM) for Use With GliaSite(R) in Treating Glioblastomas and Metastatic Brain Cancers

周二, 01/07/2014 - 17:32
RICHLAND, WA--(Healthcare Sales & Marketing Network) - IsoRay Inc. (NYSE MKT: ISR) (www.isoray.com), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced today that the FDA has cleared liquid ces...
Devices, Oncology, FDA
IsoRay, Cesitrex, liquid cesium, GliaSite, Glioblastoma, radiotherapy

Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman

周二, 01/07/2014 - 17:28
Industry veteran and oncologist strengthens management team as G1 advances lead product candidate toward IND status CHAPEL HILL, N.C., Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- G1 Therapeutics, Inc. today announced that it has named Set...
Biopharmaceuticals, Oncology, Personnel
G1 Therapeutics, chemotherapy-induced myelosuppression

Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer

周二, 01/07/2014 - 17:25
NEW YORK, Jan. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Cortice Biosciences, a biotechnology company developing novel agents for the treatment of oncologic and neurologic indications, announced today the appointment of George Farmer, Ph.D. as C...
Biopharmaceuticals, Oncology, Personnel
Cortice Biosciences, TPI 287, abeotaxane, taxane, paclitaxel

Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance

周二, 01/07/2014 - 17:23
Unique Interventional Device is Designed to Simplify In-Office Treatment of Sinusitis PALO ALTO, Calif.--(Healthcare Sales & Marketing Network)--SinuSys™ Corporation, an innovative sinus health company, today announced the Company has received FDA clear...
Devices, FDA
SinuSys, Vent-Os, Sinus Dilation, sinusitis

Allergan, Inc. and Medytox, Inc. Complete Licensing Agreement

周二, 01/07/2014 - 17:20
IRVINE, Calif. & SEOUL, South Korea--(Healthcare Sales & Marketing Network)--Allergan, Inc., (AGN) and Medytox, Inc. today announced that they have closed the license agreement which was previously announced on September 25, 2013. Under the terms of the ag...
Biopharmaceuticals, Licensing
Allergan, Medytox, botulinum toxin, neurotoxin

Oculus Innovative Sciences Introduces Two New Microcyn(R) Advanced Wound Care Products for U.S. Prescription Wound Care Market

周二, 01/07/2014 - 17:16
New three-ounce Microcyn(R) Skin & Wound Spray HydroGel delivers wound hydrogel to entire wound site via innovative spray application Microcyn Skin & Wound Care now available in convenient two-ounce bottle for both clinical and economical in-home patien...
Devices, Wound Care, Product Launch
Oculus Innovative Sciences, Microcyn, HydroGel

Guided Therapeutics Names Gene Cartwright as Chief Executive Officer

周二, 01/07/2014 - 16:38
NORCROSS, Ga.--(Healthcare Sales & Marketing Network)--Guided Therapeutics, Inc. (GTHP) (GTHP), the maker of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly at the point of care, today announced the a...
Devices, Diagnostics, Oncology, Personnel
Guided Therapeutics, LuViva, Advanced Cervical Scan

Forma Therapeutics Appoints Christopher Dinsmore to Vice President, Medicinal and Computational Chemistry

周二, 01/07/2014 - 16:34
WATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--FORMA Therapeutics announced today that Christopher Dinsmore, Ph.D., has been appointed to the position of Vice President, Medicinal and Computational Chemistry. Dr. Dinsmore joins FORMA after a dis...
Biopharmaceuticals, Personnel
Forma Therapeutics

Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch

周二, 01/07/2014 - 16:24
HAYWARD, Calif. & CUPERTINO, Calif.--(Healthcare Sales & Marketing Network)--Impax Laboratories, Inc.(IPXL) and DURECT Corporation (DRRX) announced today that they have entered into an agreement granting Impax the exclusive worldwide rights to develop and ...
Biopharmaceuticals, Drug Delivery
Impax Laboratories, DURECT Corp, transdermal, bupivacaine

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong